Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Merck KGaA Buys Lab Equipment Maker Beijing Skywing

publication date: Jan 5, 2011
Merck KGaA of Germany has acquired Beijing Skywing Technology, paying 120 million RMB ($18.2 million). Skywing makes cell culture media products and bioreactors, along with providing related services. Merck will add the company to its Millipore Division, a US-based laboratory supply company that Merck bought for $7.2 billion in March 2010. Merck touted Skywing’s close relationships with China vaccine makers as part of its rationale for the purchase. More details....

Stock Symbol: (Xetra: MRK)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital